These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 27031684)
1. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Cho A; Wrammert J Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684 [TBL] [Abstract][Full Text] [Related]
2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth. Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999 [TBL] [Abstract][Full Text] [Related]
3. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
8. Biochemistry. Catching a moving target. Wang TT; Palese P Science; 2011 Aug; 333(6044):834-5. PubMed ID: 21836007 [No Abstract] [Full Text] [Related]
9. Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge. Kuenstling TE; Sambol AR; Hinrichs SH; Larson MA Sci Rep; 2018 Aug; 8(1):11856. PubMed ID: 30087372 [TBL] [Abstract][Full Text] [Related]
10. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889 [TBL] [Abstract][Full Text] [Related]
11. An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody. Yan L; Wang H; Sun L; Liu Y; Sun J; Zhao X; Li Y; Xie X; Hu J Biochem Biophys Res Commun; 2019 Oct; 518(2):319-324. PubMed ID: 31421820 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus. Lin X; Yang F; Yan S; Wu H; Wang P; Zhao Y; Shi D; Yao H; Wu H; Li L Virus Res; 2024 Jul; 345():199402. PubMed ID: 38772446 [TBL] [Abstract][Full Text] [Related]
13. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic. Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747 [TBL] [Abstract][Full Text] [Related]
14. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies. Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038 [TBL] [Abstract][Full Text] [Related]
15. The Quest for a Universal Flu Vaccine: Headless HA 2.0. Krammer F Cell Host Microbe; 2015 Oct; 18(4):395-7. PubMed ID: 26468743 [TBL] [Abstract][Full Text] [Related]
16. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655 [TBL] [Abstract][Full Text] [Related]
17. Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase. Schmidt R; Holznagel E; Neumann B; Alex N; Sawatsky B; Enkirch T; Pfeffermann K; Kruip C; von Messling V; Wagner R Vaccine; 2016 Oct; 34(44):5329-5335. PubMed ID: 27616472 [TBL] [Abstract][Full Text] [Related]
18. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; GarcĂa-Sastre A; Albrecht RA J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585 [TBL] [Abstract][Full Text] [Related]
19. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins. Ross TM J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379 [TBL] [Abstract][Full Text] [Related]
20. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]